Abstract
One of the challenges in anti-cancer drug delivery systems is to quantitatively discriminate non-specific receptor-independent tumor accumulation from receptor-mediated uptake into the tumor cells. To overcome this challenge, we develop a new near infrared fluorescence resonance energy transfer fluorescence lifetime imaging (NIR FRET FLIM) technique with wide-field illumination strategies to validate and characterize cellular uptake in both cancer cells and normal cells with different donor-acceptor ratios in vitro and in vivo. Our results demonstrate that NIR FRET FLIM can quantitatively distinguish receptor-bound from unbound donor in live animals with high sensitivity and high accuracy. Thus, it has a great potential for the quantitative detection of targeted delivery systems for diagnostic and therapeutic use.
© 2013 SPIE
PDF ArticleMore Like This
Ken Abe, Lingling Zhao, Xavier Intes, and Margarida Barroso
QTu3G.5 Quantitative Medical Imaging (QMI) 2013
A. Rudkouskaya, S. Chen, N. Sinsuebphon, J. E. Mazurkiewicz, M. Ochoa, X. Intes, and M. Barroso
OW5D.4 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2019
Alena Rudkouskaya, Nattawut Sinsuebphon, Xavier Intes, and Margarida Barroso
CTh2A.5 Cancer Imaging and Therapy (Cancer) 2016